# Placenta Previa

Placenta previa requires transvaginal confirmation, assessment for vasa previa and placenta accreta spectrum, and individualized planning that balances recurrent hemorrhage against prematurity. Complete or partial os coverage precludes vaginal delivery; low-lying placentas require internal-os distance–based counseling and delivery planning.

**Clinical question:** How should placenta previa be confirmed, risk-stratified, and managed to reduce hemorrhage while avoiding unnecessary prematurity?

Updated: 2026-08-21T01:23:32.218963+00:00

## What matters in practice
- Use transvaginal ultrasonography to confirm suspected previa or low-lying placenta, define internal-os distance and placental features, and assess associated conditions. [9][10]
- Placenta previa is an indication for cesarean delivery; planned cesarean for asymptomatic previa is generally recommended at 36 0/7 to 37 6/7 weeks. [10][19]
- A current previa, particularly with prior cesarean delivery, should trigger focused evaluation for placenta accreta spectrum and planning at an appropriately resourced center if suspected. [1][2][20][21]
- For low-lying placenta, delivery counseling should be based on measured placental-edge distance from the internal os; evidence summarized in recent review supports trial of labor at 11–20 mm. [10]

## Confirm placental location with transvaginal ultrasound

Transvaginal imaging determines whether vaginal birth is unsafe and identifies associated placental risks.

Placenta previa is complete or partial placental coverage of the internal cervical os. A low-lying placenta is commonly defined as a placental edge within 2 cm of the os without coverage. [19][20]

When transabdominal sonography suggests or cannot exclude previa or a low-lying placenta, perform transvaginal ultrasound. This is the diagnostic gold standard and should document placental location and laterality, the placental-edge to internal-os distance, and relevant morphology such as edge thickness or marginal sinus. [9][10]

At the same examination, evaluate for conditions that alter delivery planning: placenta accreta spectrum (PAS), vasa previa, succenturiate lobe, and cord insertion near the cervix. Color mapping and pulsed-wave Doppler by transvaginal ultrasound are recommended to diagnose vasa previa or related variants. [9][10]
- Do not perform a digital cervical examination for bleeding of uncertain placental location until ultrasound has excluded previa. A sterile speculum examination may be used to assess bleeding. [22]
- Classify fetal vessels less than 2 cm from the cervical os as vasa previa; vessels 2–5 cm from the os are classified as low-lying fetal vessels in the cited guideline. [9]
- A diagnosis of vasa previa or low-lying fetal vessels made remote from delivery should be reconfirmed closer to delivery. [9]

*Ultrasound findings that direct obstetric planning. [9][10][19][20]*

| Finding | Clinical implication | Next action |
| --- | --- | --- |
| Placenta covering the internal os | Placenta previa; vaginal delivery is unsafe. [19][20] | Plan cesarean delivery; assess hemorrhage history and evaluate for PAS and vasa previa. [10][19] |
| Placental edge within 2 cm but not covering the os | Low-lying placenta; delivery route depends on measured internal-os distance and clinical context. [10][20] | Document exact distance with transvaginal ultrasound and reassess delivery planning. [9][10] |
| Fetal vessels <2 cm from the os | Vasa previa. [9] | Confirm with transvaginal color and pulsed-wave Doppler and establish delivery planning for vasa previa. [9] |
| Previa with prior cesarean delivery or suspicious placental invasion | Higher likelihood of PAS and major hemorrhagic morbidity. [1][2][20] | Obtain expert PAS assessment and plan delivery at a center with multidisciplinary hemorrhage capability if PAS is suspected. [21] |

## Identify hemorrhage and accreta-spectrum risk early

The major management pivot is whether previa is isolated or associated with PAS risk.

Placenta previa is associated with maternal and neonatal morbidity, principally antepartum hemorrhage, postpartum hemorrhage, preterm birth, and the consequences of emergent delivery. It is also a major risk factor for PAS. [2][19][20]

Risk factors for previa and PAS overlap. Older maternal age, prior cesarean delivery, and placenta previa identified before birth were independent risk factors for placenta accreta in a cohort study. [1] Repeated cesarean delivery increases later risks of placenta previa, PAS, and gravid hysterectomy. [8]

The combination of current previa and prior cesarean delivery deserves particular scrutiny because most PAS occurs in this setting. Antenatal recognition permits referral, planned delivery, blood-bank preparation, and multidisciplinary surgical support rather than emergency response to hemorrhage. [20][21][23]
- Consider in-hospital management for previa or low-lying placenta when risk factors are present or access to urgent obstetric care is limited. [9]
- Urgent maternal or fetal indications override attempts to complete planned preterm interventions; severe antepartum hemorrhage is an example of an emergency requiring prompt delivery. [3]

*Risk features that should change the level of surveillance or delivery preparation. [1][2][8][9][20][21]*

| Risk feature | Why it matters | Operational implication |
| --- | --- | --- |
| Prior cesarean delivery | Increases risk of previa, PAS, and gravid hysterectomy in subsequent pregnancies. [8] | Review prior uterine surgery and evaluate carefully for PAS when previa is present. [20][21] |
| Placenta previa with prior cesarean delivery | A high-risk context for PAS. [20][23] | Use expert imaging assessment and anticipate need for specialized delivery resources. [21] |
| Recurrent or severe bleeding | Signals risk of urgent delivery and maternal hemorrhage. [3][19] | Assess maternal stability and fetal status; deliver without delay when emergency criteria are met. [3] |
| Limited rapid access to obstetric care | Delay during hemorrhage can increase risk. [9] | Consider inpatient management. [9] |

## Manage bleeding episodes according to maternal-fetal urgency

Management must preserve pregnancy only when maternal and fetal conditions permit.

Painless second- or third-trimester bleeding is a common presentation, but management should begin with hemodynamic assessment, fetal evaluation, and confirmation of placental location if unknown. Absence of visible bleeding does not exclude placental abruption, which remains an important alternative diagnosis when pain, uterine tenderness, hypertonus, or fetal compromise is present. [19][22]

For a stable patient, use the clinical course, placental location, PAS risk, gestational age, and feasibility of rapid return to obstetric care to determine outpatient versus inpatient management. The cited guideline supports considering hospitalization when there are risk factors or limited access to urgent care. [9]

Do not delay an indicated emergency cesarean for antenatal interventions. In a magnesium sulfate protocol study, urgent delivery included category III fetal heart rate tracing, severe antepartum hemorrhage, and abruption; severe hemorrhage was treated as a maternal emergency requiring delivery in the shortest time. [3]
- In acute bleeding, quantify blood loss, obtain vital signs, evaluate maternal perfusion, and assess fetal status; tachycardia or hypotension may indicate hemorrhagic hypovolemia. [22]
- Use ultrasound to establish placental location and assess for previa, but do not use a negative ultrasound alone to exclude abruption. [22]
- If preterm delivery is likely but not immediately required, use antenatal corticosteroids and magnesium sulfate for fetal neuroprotection according to standard obstetric gestational-age guidance; available evidence indicates pregnancy with HIV does not alter these usual obstetric recommendations. [24]

## Choose delivery route and timing by os relationship and hemorrhage risk

A measured internal-os distance and the presence of bleeding or PAS determine the safest delivery plan.

Placenta previa is an absolute indication for cesarean delivery. For asymptomatic placenta previa, a recent review reports planned cesarean delivery is generally recommended between 36 0/7 and 37 6/7 weeks, with some practices favoring earlier delivery within this interval for anterior previa. Earlier delivery is appropriate when maternal hemorrhage or fetal status requires it. [10]

Low-lying placenta is not equivalent to previa. The placental-edge to internal-os distance should be documented transvaginally and used for shared delivery planning. Evidence summarized in a recent review supports a trial of labor when the distance is 11–20 mm; the same review notes that low-lying placenta requires distance-guided planning rather than automatic cesarean delivery. [10] Other cited summaries describe increased postpartum hemorrhage and emergent cesarean risk even when the edge is more than 2 cm from the os, underscoring the need for individualized intrapartum preparedness. [19]

Suspected PAS changes both timing and site of delivery. ACOG-referenced guidance summarized in the supplied literature recommends planned cesarean hysterectomy at 34 0/7 to 35 6/7 weeks, with delivery at a level III or IV center or PAS center of excellence and access to a multidisciplinary team. [21]
- Before planned cesarean for previa, communicate placental laterality and whether the placenta is anterior, assess for PAS and vasa previa, and prepare for hemorrhage. [9][10][21]
- For suspected PAS, multidisciplinary planning should include maternal-fetal medicine, experienced pelvic surgeons, anesthesia, blood bank, critical care, urology and neonatal services as locally indicated. [21]
- Objective monitoring during PAS surgery includes blood loss, hemoglobin, electrolytes, blood gas values, and coagulation parameters to guide resuscitation and transfusion. [21]

### Hemorrhage preparedness when PAS is suspected

PAS delivery planning should include a massive-transfusion strategy. The cited ACOG-referenced summary describes commonly used 1:1:1 packed red blood cell:fresh frozen plasma:platelet resuscitation, while emphasizing laboratory and clinical reassessment. [21] Tranexamic acid 1 g intravenously within 3 hours of delivery can be considered for postpartum hemorrhage treatment; this is not presented in the supplied evidence as routine prophylaxis for uncomplicated previa. [21]
- After cesarean hysterectomy for PAS, intensive care monitoring is recommended for bleeding, hypoperfusion, and fluid overload after resuscitation. [21]

*Delivery planning by placental relationship to the internal os and invasion risk. [10][19][21]*

| Clinical category | Route of delivery | Timing or planning point |
| --- | --- | --- |
| Placenta previa | Cesarean delivery. [10][19] | If asymptomatic, generally plan cesarean at 36 0/7–37 6/7 weeks; deliver earlier for bleeding or fetal indications. [10] |
| Low-lying placenta, edge 11–20 mm from os | Trial of labor may be supported by current evidence summarized in review. [10] | Use individualized counseling and hemorrhage-ready intrapartum planning. [10][19] |
| Low-lying placenta with delivery decision uncertain | Route should incorporate exact ultrasound distance, history, risk factors, and unit resources. [9][10] | Repeat transvaginal localization when clinically relevant to delivery planning. [9][10] |
| Suspected PAS with previa | Planned cesarean hysterectomy is the ACOG-referenced standard approach in the supplied summary. [21] | Plan delivery at 34 0/7–35 6/7 weeks in a level III/IV or PAS-experienced center when clinically stable. [21] |

## Communicate the evolving diagnosis and future pregnancy implications

Counseling should separate a transient midtrimester low placental position from persistent previa near delivery.

Placenta previa is observed in up to 10% of midtrimester scans but has a delivery prevalence of approximately 0.5%–1%. Therefore, a midtrimester low placental location should prompt follow-up localization rather than premature certainty about delivery route. [10]

Patients with prior cesarean delivery should understand that repeat cesareans increase risks of subsequent placenta previa, PAS, and gravid hysterectomy. This discussion is especially consequential when current placenta previa raises concern for invasive placentation. [8][20]
- Advise patients with known previa to seek immediate obstetric assessment for vaginal bleeding, contractions, rupture of membranes, or reduced fetal movement; bleeding can become emergent rapidly. [3][19]
- Explain that a low-lying placenta does not automatically require cesarean delivery, whereas placental coverage of the internal os does. [10][19]

## Common questions

### Is transvaginal ultrasound safe and necessary when placenta previa is suspected?

Yes. Transvaginal ultrasound is the diagnostic gold standard for confirming placental location, measuring internal-os distance, and evaluating associated PAS and vasa previa findings. [9][10]

### When should a patient with placenta previa be delivered?

For asymptomatic placenta previa, planned cesarean delivery is generally recommended at 36 0/7 to 37 6/7 weeks. Maternal hemorrhage or fetal compromise warrants earlier delivery when clinically indicated. [10]

### Can a patient with a low-lying placenta attempt vaginal delivery?

Potentially. Delivery planning should use the transvaginally measured placental-edge to internal-os distance. A recent review supports trial of labor when the distance is 11–20 mm, with individualized counseling and hemorrhage preparedness. [10]

### When should placenta previa prompt concern for placenta accreta spectrum?

Concern is highest when previa coexists with prior cesarean delivery. Older maternal age, prior cesarean delivery, and previa are reported PAS risk factors; suspected PAS should prompt expert assessment and specialized delivery planning. [1][20][21]

### Should a digital cervical examination be performed during bleeding in a pregnancy with unknown placental location?

No. Delay digital cervical examination until sonography establishes placental location and excludes placenta previa; a sterile speculum examination may be performed to assess bleeding. [22]

## References
1. Incidence, risk factors and perinatal outcomes for placenta ... — bmjopen.bmj.com — https://bmjopen.bmj.com/content/7/10/e017713
2. Epidemiology of placenta previa accreta: a systematic ... — bmjopen.bmj.com — https://bmjopen.bmj.com/content/9/11/e031193
3. Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants | Scientific Reports — www.nature.com — https://www.nature.com/articles/srep14732
4. Obstetric Care Consensus No. 7: Placenta Accreta... : Obstetrics & Gynecology — journals.lww.com — https://journals.lww.com/greenjournal/fulltext/10.1097/aog.0000000000002983~obstetric-care-consensus-no-7-placenta-accreta-spectrum
5. Placenta Praevia and Placenta Accreta Spectrum:... : BJOG: An International Journal of Obstetrics and Gynaecology — journals.lww.com — https://journals.lww.com/00134415-202609000-00023
6. Placenta Praevia and Placenta Accreta Spectrum: Diagnosis ... — obgyn.onlinelibrary.wiley.com — https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.70239
7. Placenta accreta spectrum disorders clinical practice ... — obgyn.onlinelibrary.wiley.com — https://obgyn.onlinelibrary.wiley.com/doi/10.1111/jog.15544
8. ACOG Committee Opinion No. 761: Cesarean Delivery... : Obstetrics & Gynecology — journals.lww.com — https://journals.lww.com/greenjournal/fulltext/10.1097/aog.0000000000003006~acog-committee-opinion-no-761-cesarean-delivery-on-maternal
9. Guideline No. 402: Diagnosis and Management of Placenta Previa — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1701216319307261
10. Cesarean delivery for placenta previa — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0002937825006623
11. Complete placenta previa and increta after radical ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2352578923003247
12. Automatic Image Guidance for Assessment of Placenta ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0301562922005294
13. Diagnosis and Management of Placenta Previa — journals.lww.com — https://journals.lww.com/postgradobgyn/fulltext/2008/10310/diagnosis_and_management_of_placenta_previa.1.aspx
14. Quality evaluation of clinical practice guidelines for placenta accreta spectrum disorders - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10988008
15. Guideline No. 402: Diagnosis and Management of Placenta Previa - PubMed — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/32591150
16. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a - PubMed — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/30260097
17. Guidelines on Placenta Accreta Spectrum Disorders — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC12274978
18. New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC6929563
19. Placenta Previa - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK539818
20. Placenta Abnormalities - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK459355
21. Placenta Accreta - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK563288
22. Placental Abruption - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK482335
23. Placenta Accreta Spectrum | NeoReviews — publications.aap.org — https://publications.aap.org/neoreviews/article/22/11/e722/181268/Placenta-Accreta-Spectrum
24. Special Populations: Intrapartum Care for People With HIV — clinicalinfo.hiv.gov — https://clinicalinfo.hiv.gov/en/guidelines/perinatal/intrapartum-care

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.